Bioequivalence Study of Favipiravir From Flupirava 200 mg Tablet (European Egyptian Pharmaceutical Industries , Egypt) Versus Avigan 200 mg Tablets (Man. by Toyama Chemical Co., Ltd Japan)
Clinical trial NCT04478448 · COMPLETED
Trial details
- NCT number
- NCT04478448
- Sponsor
- Genuine Research Center, Egypt
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-13
- Primary completion
- 2020-08-20
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.